Document:

Exhibit 4.2

 

NEITHER THIS SECURITY NOR THE SECURITIES AS TO
WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH
SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON SHARE PURCHASE WARRANT

 

1847 HOLDINGS LLC

 

Warrant Shares: ___________

Date of Issuance: ____________, 2022 (“Issuance
Date”)

 

This COMMON SHARE PURCHASE
WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of Series B Senior Convertible
Preferred Shares to the Holder (as defined below) of even date (the “Preferred Shares”), _____________ (including any
permitted and registered assigns, each a “Holder”), is entitled, upon the terms and subject to the limitations on exercise
and the conditions hereinafter set forth, at any time within three (3) years after the date of issuance hereof, to purchase from 1847
Holdings LLC, a Delaware limited liability company (the “Company”), up to ____________ Common Shares (the “Warrant
Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the
Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities
purchase agreement, dated ___________, 2022, by and between the Company and the Holder (the “Purchase Agreement”).

 

Capitalized terms used in
this Warrant shall have the meanings set forth in the Purchase Agreement unless otherwise defined in the body of this Warrant or in Section
13 below. For purposes of this Warrant, the term “Exercise Price” shall mean $3.00, subject to adjustment as provided
herein (including but not limited to cashless exercise), and the term “Exercise Period” shall mean the period commencing
on the Issuance Date and ending on 6:00 p.m. eastern standard time on the three-year anniversary thereof.

 

    1

    

    

 

 1. EXERCISE OF WARRANT.

 

(a)  Subject
to the terms and conditions hereof, the rights represented by this Warrant may be exercised in whole or in part at any time or times during
the Exercise Period by delivery of a written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”),
of the Holder’s election to exercise this Warrant. The Holder shall not be required to deliver the original Warrant in order to
effect an exercise hereunder. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. On or before the third Trading Day (the “Warrant Share Delivery Date”)
following the date on which the Company shall have received the Exercise Notice, and upon receipt by the Company of payment of an amount
equal to the applicable Exercise Price multiplied by the number of Warrant Shares as to which all or a portion of this Warrant is being
exercised (the “Aggregate Exercise Price” and together with the Exercise Notice, the “Exercise Delivery Documents”)
in cash or by wire transfer of immediately available funds (or by cashless exercise, in which case there shall be no Aggregate Exercise
Price provided), the Company shall cause the Warrant Shares purchased hereunder to be transmitted by its transfer agent to the Holder
by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit
or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there
is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder, or
(B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 and, in
either case, the Warrant Shares have been sold by the Holder prior to the Warrant Share Delivery Date (as defined below), and otherwise
by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for
the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Exercise
Delivery Documents. If the Warrant Shares must be delivered in certificated form, the Company shall (or direct its transfer agent to)
issue and dispatch by overnight courier to the address as specified in the Exercise Notice, a certificate, registered in the Company’s
share register in the name of the Holder or its designee, for the number of Common Shares to which the Holder is entitled pursuant to
such exercise or, with the written consent of the Holder, such Warrant Shares may be issued in book entry form at the transfer agent.
Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the holder of record
of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the certificates
evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and the number of Warrant Shares represented
by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise, then the Company
shall, at the written request of the Holder, as soon as practicable and in no event later than three (3) Business Days following such
request and at the Company’s expense, issue a new Warrant (in accordance with Section 7) representing the right to purchase the
number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect
to which this Warrant is exercised.

 

If the Company fails to cause
its transfer agent to transmit to the Holder the respective Common Shares by the respective Warrant Share Delivery Date, then the Holder
will have the right to rescind such exercise in Holder’s sole discretion, and such failure shall be deemed an event of default under
the Purchase Agreement to the extent any securities issued thereunder remain outstanding and are held by the Holder.

 

    2

    

    

 

If at any time after the 6-month
anniversary of the Issuance Date, the Market Price of one Common Share is greater than the Exercise Price and the Warrant Shares are not
registered under an effective non- stale registration statement of the Company, the Holder may elect to receive Warrant Shares pursuant
to a cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described below (or of
any portion thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in which event the Company shall issue
to Holder a number of Common Shares computed using the following formula:

 

X = Y (A-B)

 

A

 

		Where	X = the number of Shares to be issued to Holder.

 

 Y = the number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date of such calculation).

 

A =  the Market
Price (at the date of such calculation).

 

B =  Exercise Price
(as adjusted to the date of such calculation).

 

(b)  No fractional
shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment pursuant hereto. All Warrant Shares (including
fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining whether the exercise would result in the
issuance of any fractional share. If, after aggregation, the exercise would result in the issuance of a fractional share, the Company
shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction a sum in cash equal to the product
resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.

 

(c)  The
Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant,
to the extent that after giving effect to issuance of Warrant Shares upon exercise as set forth on the applicable Notice of Exercise,
the Holder (together with the Holder’s Affiliates, and any other persons acting as a group together with the Holder or any of the
Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation, as defined below. For purposes of
the foregoing sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates shall include the number of Common
Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of
Common Shares which would be issuable upon (i) exercise of the remaining, non-exercised portion of this Warrant beneficially owned by
the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or non-converted portion of any other securities,
including the Preferred Shares, of the Company (including without limitation any other Common Share Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except
as set forth in the preceding sentence, for purposes of this paragraph (c), beneficial ownership shall be calculated in accordance with
Section 13(d) of the Exchange Act, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained in this paragraph applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any affiliates) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination.

 

    3

    

    

 

For purposes of this paragraph,
in determining the number of outstanding Common Shares, a Holder may rely on the number of outstanding Common Shares as reflected in (A)
the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement
by the Company or (C) a more recent written notice by the Company or its transfer agent setting forth the number of Common Shares outstanding.
Upon the request of a Holder, the Company shall within two Trading Days confirm to the Holder the number of Common Shares then outstanding.
In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its affiliates since the date as of which such number of outstanding Common Shares
was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of Common Shares outstanding immediately
after giving effect to the issuance of Common Shares issuable upon exercise of this Warrant. Upon no fewer than sixty-one (61) days’
prior notice to the Company, a Holder may increase or decrease the Beneficial Ownership Limitation provisions of this paragraph and the
provisions of this paragraph shall continue to apply. Any such increase or decrease will not be effective until the sixty-first (61st)
day after such notice is delivered to the Company and shall only apply to such Holder and no other Holder. The limitations contained in
this paragraph shall apply to a successor Holder of this Warrant.

 

(d)  The
Holder understands and covenants that if, at any time following the one year anniversary of the date of this Warrant, (i) the Company
is listed on a national securities exchange or the over- the-counter market, (ii) Warrant Shares are registered or the Holder otherwise
has the ability to trade the Warrant Shares without restriction, (iii) the 30-day volume-weighted daily average price of the Company’s
Common Stock exceeds two hundred percent (200%) of the Exercise Price, as adjusted and (ii) the average daily trading volume is at least
100,000 Common Shares during such 30-day period, the Holder shall be required to fully exercise the Warrant within ten (10) business days
of receiving written notice from the Company following the aforementioned 30th trading day and if the Holder does not so exercise the
Warrant, then it shall automatically expire. The Holder shall furnish the Company with a completed and fully executed Notice to Exercise
attached to this Warrant and, if exercised for cash, remit the funds pursuant to the Notice to Exercise.

 

    4

    

    

 

 2. ADJUSTMENTS. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

 

(a)  If the
Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes a distribution or distributions on
Common Shares or any other equity or equity equivalent securities payable in Common Shares (which, for avoidance of doubt, shall not include
any Common Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding Common Shares into a larger number
of shares, (iii) combines (including by way of reverse stock split) outstanding Common Shares into a smaller number of shares, or (iv)
issues by reclassification of Common Shares any membership interests of the Company, then in each case the Exercise Price shall be multiplied
by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event,
and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price
of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 2(b) shall become effective immediately after the
record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately
after the effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise
Price of this Warrant will not be adjusted in the event that the Company or any subsidiary thereof, as applicable, sells or grants any
option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any
option to purchase or other disposition) any Common Shares or Common Share Equivalents, at an effective price per share less than the
Exercise Price then in effect.

 

(b)  If at
any time while this Warrant is outstanding, the Company sells or grants (or has sold or granted, as the case may be) any option to purchase
or sells or grants any right to reprice, or otherwise disposes of or issues (or has sold or issued, as the case may be, or announces any
sale, grant or any option to purchase or other disposition), any Common Share or other securities convertible into, exercisable for or
otherwise entitles any person or entity the right to acquire Common Shares at an effective price per share that is lower than the then
Exercise Price (such lower price, the “Base Exercise Price” and such issuances, collectively, a “Dilutive
Issuance”) (it being agreed that if the holder of the Common Share or other securities so issued shall at any time, whether
by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to
warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive Common Shares at an effective
price per share that is lower than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price
on such date of the Dilutive Issuance), then the Exercise Price shall be reduced to a price equal to the Base Exercise Price. Such adjustment
shall be made whenever such Common Share or other securities are issued, provided however, that no adjustment will be made under this
Section 2(b) in respect of an Excluded Issuance. In the event of an issuance of securities involving multiple tranches or closings, any
adjustment pursuant to this Section 2(b) shall be calculated as if all such securities were issued at the initial closing. For purposes
of this Section 2(b), an “Excluded Issuance” means the issuance of (a) Common Shares or options to employees, officers
or directors of the Company or consultants to the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority
of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established
for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any securities
exercisable or exchangeable for or convertible into Common Shares issued and outstanding on the date of this Warrant, provided that such
securities have not been amended since the date of this Warrant to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend
the term of such securities, (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company or securities issued in financing transactions, the primary purpose of which is to finance acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company, (d), Common Shares, options or convertible securities
issued to banks, equipment lessors or other financial institutions, or to real property lessors, pursuant to a debt financing, equipment
leasing or real property leasing transaction approved by a majority of the disinterested directors of the Company, (e) Common Shares,
options or convertible securities issued to in connection with the provision of goods pursuant to transactions approved by a majority
of the disinterested directors of the Company and (f) Common Shares, options or convertible securities issued in connection with sponsored
research, collaboration, technology license, development, marketing or other similar agreements or strategic partnerships approved a majority
of the disinterested directors of the Company.

 

    5

    

    

 

 3. REDEMPTION OF WARRANTS.

 

(a)  The
Company may redeem the Warrants held by the Holder in whole (but not in part) by paying in cash (the “Redemption Price”)
to the Holder as follows: (i) $0.50 per Warrant Share then underlying this Warrant if within the first twelve (12) months; (ii) $1.00
per Warrant Share then underlying this Warrant if after the first twelve (12) months, but before twenty-four (24) months; and (iii) $1.50
per Warrant Share then underlying this Warrant if after twenty-four months, but before thirty-six (36) months.

 

(b)  The
Company shall mail written notice of the redemption (the “Redemption Notice”) of any of the Warrant under this Section
3, postage prepaid, to the Holder of the Warrant to be redeemed at the address of Holder as shown on the Company’s stock transfer
records, not less than fifteen (15) nor more than thirty (30) days prior to the Redemption Date as set forth in the Redemption Notice;
provided, however, that Holder subject to such Redemption Notice shall have the right to exercise Holder’s Warrant
into Warrant Shares in accordance with Section 1 hereof prior to the Redemption Date in lieu of the Redemption Price. Neither the failure
to give notice required by this Section 3(b), nor any defect in the notice therein or in the mailing thereof, to any particular holder,
shall affect the validity of the redemption proceedings with respect to the other holders. Any notice mailed in the manner herein provided
shall be conclusively presumed to have been duly given on the date mailed whether or not Holder receives the notice. Each such mailed
notice shall state, as appropriate: (i) the Redemption Date; (ii) the applicable Redemption Price; (iii) the number of underlying Warrant
Shares to be redeemed; and (iii) that the Warrants are being redeemed pursuant to the Company’s redemption right under Section 3(a)
hereof. If a notice of redemption is duly mailed as aforesaid, then from and after the Redemption Date, all rights of the Holder thereof
as a holder of the Warrant shall cease (except the right to receive cash payable upon such redemption, without interest thereon, upon
surrender and endorsement of their certificates if so required and to receive any dividends payable thereon); provided, however, that
no such rights shall terminate if the Company fails to provide funds sufficient to complete the redemption at the time and place specified
for payment pursuant to the applicable redemption notice.

 

    6

    

    

 

4.  FUNDAMENTAL
TRANSACTIONS. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company with or into another
entity and the Company is not the surviving entity (such surviving entity, the “Successor Entity”), (ii) the Company
effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender offer or exchange
offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant to which holders
of Common Shares are permitted to tender or exchange their Common Shares for other securities, cash or property and the holders of at
least fifty percent (50%) of the Common Shares accept such offer, or (iv) the Company effects any reclassification of the Common Shares
or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of Common Shares) (in any such case, a “Fundamental
Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive the number of
Common Shares of the Successor Entity or of the Company and any additional consideration (the “Alternate Consideration”)
receivable upon, or as a result of, such reorganization, reclassification, merger, consolidation, or disposition of assets by a holder
of the number of Common Shares for which this Warrant is exercisable immediately prior to such event (disregarding any limitation on exercise
contained herein solely for the purpose of such determination). For purposes of any such exercise, the determination of the Exercise Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental Transaction shall issue to the
Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right to exercise such warrant into Alternate
Consideration.

 

5.  NON-CIRCUMVENTION.
The Company covenants and agrees that it will not, by amendment of its certificate of formation, operating agreement or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out
all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality
of the foregoing, the Company (i) shall not increase the par value of any Common Shares receivable upon the exercise of this Warrant above
the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and non-assessable Common Shares upon the exercise of this Warrant, and (iii) shall, for so long as this
Warrant is outstanding, have authorized and reserved, free from preemptive rights, a sufficient number of Common Shares to provide for
the exercise of the rights represented by this Warrant (without regard to any limitations on exercise).

 

6.  WARRANT
HOLDER NOT DEEMED A SHAREHOLDER. Except as otherwise specifically provided herein, this Warrant, in and of itself, shall not entitle
the Holder to any voting rights or other rights as a shareholder of the Company. In addition, nothing contained in this Warrant shall
be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a
shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.

 

    7

    

    

 

7.  REISSUANCE.

 

(a)  If this
Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms as to indemnity or otherwise as it may reasonably impose
(which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination and tenor as
this Warrant so lost, stolen, mutilated or destroyed.

 

(b)  Whenever
the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant shall be of like tenor with this
Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date.

 

8.  TRANSFER.

 

(a)  The
Holder agrees that, if practicable, but without any obligation to do so, it will give written notice to the Company of its intent to transfer
this Warrant or any Warrant Shares, describing briefly the manner of any proposed transfer. Promptly upon receiving such written notice,
the Company shall present copies thereof to the Company’s counsel. If the proposed transfer may be effected without registration
or qualification (under any federal or state securities laws), the Company, as promptly as practicable, shall notify the Holder thereof,
whereupon the Holder shall be entitled to transfer this Warrant or to dispose of Warrant Shares received upon the previous exercise of
this Warrant, all in accordance with the terms of the notice delivered by the Holder to the Company; provided, however, that an appropriate
legend may be endorsed on this Warrant or the certificates for such Warrant Shares respecting restrictions upon transfer thereof necessary
or advisable in the opinion of counsel and satisfactory to the Company to prevent further transfers which would be in violation of Section
5 of the Securities Act and applicable state securities laws; and provided further that the prospective transferee or purchaser shall
execute the Assignment of Warrant attached hereto as Exhibit B and such other documents and make such representations, warranties,
and agreements as may be required solely to comply with the exemptions relied upon by the Company for the transfer or disposition of the
Warrant or Warrant Shares.

 

(b)  If the
proposed transfer or disposition of this Warrant or such Warrant Shares described in the written notice given pursuant to this Section
8 may not be effected without registration, qualification, or other available exemption of or for this Warrant or such Warrant Shares,
the Holder will limit its activities in respect to such transfer or disposition as are permitted by law.

 

(c)  Any
transferee of all or a portion of this Warrant shall succeed to the rights and benefits of the initial Holder of this Warrant under the
terms of the Purchase Agreement.

 

9.  NOTICES.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with the notice provisions contained in the Purchase Agreement. The Company shall provide the Holder with prompt written notice (i) immediately
upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation of such adjustment and (ii) at least 20
days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the
Common Shares, (B) with respect to any grants, issuances or sales of any shares or other securities directly or indirectly convertible
into or exercisable or exchangeable for Common Shares or other property, pro rata to the holders of Common Shares or (C) for determining
rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall
be made known to the public prior to or in conjunction with such notice being provided to the Holder.

 

    8

    

    

 

10.  AMENDMENT
AND WAIVER. The terms of this Warrant may be amended or waived (either generally or in a particular instance and either retroactively
or prospectively) only with the written consent of each of the Company and the Holder.

 

11.  GOVERNING
LAW. This Warrant shall be governed by and construed in accordance with the laws of the State of New York without regard to principles
of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Warrant shall
be brought only in the state courts or federal courts located in Rockland County, New York. The parties to this Warrant hereby irrevocably
waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction
or venue or based upon forum non conveniens. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT
TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION
CONTEMPLATED HEREBY. The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees and costs.
In the event that any provision of this Warrant or any other agreement delivered in connection herewith is declared invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith
and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable
under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives
personal service of process and consents to process being served in any suit, action or proceeding in connection with this Warrant or
any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under the Purchase Agreement, or otherwise provided, and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way
any right to serve process in any other manner permitted by law.

 

12.  ACCEPTANCE.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.

 

13.  CERTAIN
DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a)  “Common
Share” means the Common Shares of the Company and any other class of securities into which such securities may hereafter be
reclassified or changed.

 

(b)  “Common
Share Equivalents” means any securities of the Company that would entitle the holder thereof to acquire at any time Common Shares,
including without limitation any debt, preferred shares, rights, options, warrants or other instrument that is at any time convertible
into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares.

 

(c)  “Principal
Market” means the primary National Securities Exchange or over the counter market on which the Common Shares are then traded.

 

(d)  “Market
Price” means the highest traded price of the Common Shares during the thirty (30) Trading Days prior to the date of the respective
Exercise Notice.

 

(e)  “Trading
Day” means (i) any day on which the Common Shares are listed or quoted and traded on its Principal Market, (ii) if the Common
Shares are not then listed or quoted and traded on any National Securities Exchange, then a day on which trading occurs on any over-the-counter
markets, or (iii) if trading does not occur on the over-the-counter markets, any Business Day.

 

(f)  “National
Securities Exchange” means a securities exchange that has registered with the Securities and Exchange Commission under Section
6 of the Securities Exchange Act of 1934.

 

[Signature Page Follows]

 

    9

    

    

 

IN WITNESS WHEREOF, the Company has caused this
Warrant to be duly executed as of the Issuance Date set forth above.

 

	 	1847 HOLDINGS LLC  
	 	 	 
	 	By:	 
	 	Name: 	Ellery W. Roberts
	 	Title: 	Chief Executive Officer

 

     

    

    

 

EXHIBIT A

 

EXERCISE NOTICE

 

(To be executed by the registered holder to exercise
this Common Share Purchase Warrant)

 

THE UNDERSIGNED holder hereby
exercises the right to purchase of the Common Shares (“Warrant Shares”) of 1847 HOLDINGS LLC, a Delaware
limited liability company (the “Company”), evidenced by the attached copy of the Common Share Purchase Warrant (the
“Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

		1.	Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as
(check one):

 

		☐	a cash exercise with respect to Warrant Shares; or

		☐	cashless exercise pursuant to the Warrant.

 

		2.	Payment of Exercise Price. If cash exercise is selected above, the holder shall pay the applicable
Aggregate Exercise Price in the sum of $ to the Company in accordance with the terms of the Warrant.

 

		3.	Delivery of Warrant Shares. The Company shall deliver to the holder Warrant Shares
in accordance with the terms of the Warrant.

 

	Date:	 	

 

	 	 
	 	(Signature)
	 	 
	 	 
	 	(Print Name of Registered Holder)

 

	 	Name:	 
	 	 	 
	 	Title:	 

 

     

    

    

 

EXHIBIT B

 

ASSIGNMENT OF WARRANT

 

(To be signed only upon authorized transfer of
the Warrant)

 

FOR VALUE RECEIVED, the undersigned
hereby sells, assigns, and transfers unto _________________ the right to purchase _________ Common Shares of 1847 HOLDINGS LLC,
a Delaware limited liability company, to which the within Common Share Purchase Warrant relates and appoints __________________, as attorney-in-fact,
to transfer said right on the books of 1847 Holdings LLC with full power of substitution and re- substitution in the premises. By accepting
such transfer, the transferee has agreed to be bound in all respects by the terms and conditions of the within Warrant.

 

	Dated:	 	

 

	 	 
	 	(Signature)*
	 	 
	 	 
	 	(Print Name of Registered Holder)
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Social Security or Tax Identification No.)

 

* The signature on this Assignment of Warrant
must correspond to the name as written upon the face of the Common Share Purchase Warrant in every particular without alteration or enlargement
or any change whatsoever. When signing on behalf of a corporation, partnership, trust or other entity, please indicate your position(s)
and title(s) with such entity.Exhibit 10.1

 

SECURITIES
PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of ___________, 2022, by and between
1847 HOLDINGS LLC, a Delaware limited liability company (the “Company”), and the undersigned subscribing investor
(the “Purchaser”).

 

RECITALS

 

A. The
Company is seeking investors to invest up to One Million, Seven Hundred Fifty Thousand Dollars ($1,750,000) (the “Offering”),
in units of Three Dollars ($3.00) each (each a “Unit” and collectively the “Units”). This Agreement
is one of a series of similar agreements being executed by other investors in this Offering (the “Investors”). The
Preferred Shares (as defined below) being issued to the Purchaser shall rank equally without preference or priority of any kind over
Preferred Shares being issued to other Investors and all payments on account of dividends or redemption with respect to any of the Preferred
Shares or the Warrants shall be applied ratably and proportionately on the basis of the Stated Value (as defined in the Designation)
of the outstanding Preferred Shares or the number of Warrant Shares (as defined in the Warrant), as applicable, represented thereby.

 

B. Each
Unit consists of one (1) Series B Senior Convertible Preferred Share (the “Preferred Share”), the share designation
of which is attached hereto as Exhibit A (the “Designation”), and one (1) warrant to purchase one (1) Common
Share, the form of which is attached hereto as Exhibit B (the “Warrant” and, together with the Preferred Share
and the Common Shares to be acquired upon the conversion of the Preferred Share and/or exercise of the Warrant, the “Securities”).

 

C. The
Warrant is exercisable for a period of three (3) years at $3.00 per Common Share.

 

D. The
Company desires to sell, and the Purchaser desires to purchase, the number of Units set forth below on the terms and conditions set forth
herein.

 

E. The
Company and the Purchaser are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) promulgated by
the United States Securities and Exchange Commission (the “SEC”) under the Securities Act.

 

NOW
THEREFORE, in consideration of the foregoing, and the representations, warranties, covenants and conditions set forth below, the Company
and the Purchaser, intending to be legally bound, hereby agree as follows:

 

		1.	PURCHASE
                                            OF UNITS

 

On
the Closing Date (as hereinafter defined), subject to the terms and conditions set forth in this Agreement, the Purchaser hereby agrees
to purchase, and the Company hereby agrees to sell, the number of Units of the Company indicated on the signature page below, at a per-unit
purchase price of Three Dollars and No Cents ($3.00), for the total purchase price set forth on the signature page below (the “Purchase
Price”).

 

     

     

    

 

		2.	CLOSING
                                            AND DELIVERY

 

2.1 Closing
Date. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below, the date
and time of the initial issuance and sale of the Units pursuant to this Agreement (the “Closing Date”) shall be 4:00
PM, Eastern Time on the date first written above, or such other mutually agreed upon time.

 

2.2 Closing.
The initial closing of the transactions contemplated by this Agreement shall occur on the Closing Date at such location as may be agreed
to by the parties (including via exchange of electronic signatures). A closing of the transactions contemplated by this Agreement is
referred to as the “Closing.”

 

2.3 Subsequent
Closings. In the full One Million, Seven Hundred Fifty Thousand Dollars ($1,750,000) is not raised at the initial Closing, the Company
may have one or more subsequent closings of the Offering until the maximum amount is raised. There may be more than one subsequent Closing
over such time period as determined by the Company.

 

2.4 Delivery.
At the initial Closing and at any subsequent Closing, or as promptly as commercially reasonable thereafter, the Purchaser shall deliver
the Purchase Price to the Company and the Company shall deliver to the Purchaser the Preferred Shares, the Warrants and such other customary
instruments of transfer, assumption, filings or documents, in form and substance reasonably satisfactory to the Purchaser, as may be
required to give effect to this Agreement.

 

		3.	REPRESENTATIONS
                                            AND WARRANTIES OF THE COMPANY

 

Except
as set forth in the corresponding section of the Disclosure Schedule delivered to the Purchaser concurrently herewith and attached hereto
as Schedule I (the “Disclosure Schedule”) or as disclosed in the Disclosure Materials (as defined below), the
Company hereby makes the following representations and warranties as of the date hereof and as of each Closing Date to the Purchaser’s
participating in such Closing:

 

3.1 Organization,
Good Standing and Qualification. The Company and each of its Subsidiaries (as defined below) is a corporation or limited liability
company duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation or organization. Each
of the Company and its Subsidiaries has the requisite corporate or limited liability company power to own and operate its properties
and assets and to carry on its business as now conducted and as proposed to be conducted. The Company and each of its Subsidiaries is
duly qualified and is authorized to do business and is in good standing as a foreign corporation or limited liability company in all
jurisdictions in which the nature of its activities and of its properties (both owned and leased) makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, would not have or reasonably be expected to result
in (a) a material adverse effect on the legality, validity or enforceability of any Subscription Document, (b) a material adverse effect
on the results of operations, assets, business or financial condition of the Company and the Subsidiaries, taken as a whole, or (c) adversely
impair the Company’s ability to perform in any material respect on a timely basis its obligations under any Subscription Document
(any of (a), (b) or (c), a “Material Adverse Effect”) provided, however, that none of the following, either alone
or taken together with other changes, events, results, occurrences, developments or effects, will constitute, or be taken into account
in determining whether there has been or will be, a Material Adverse Effect: (i) changes, events, occurrences or developments in, or
effects or results arising from or relating to, general business or economic conditions affecting the industry in which the Company and
its Subsidiaries operate, (ii) changes, events, occurrences or developments in, or effects or results arising from or relating to, national
or international political or social conditions, including the engagement by the United States in hostilities or the escalation thereof,
whether or not pursuant to the declaration of a national emergency or war, or the occurrence or the escalation of any military, cyber
or terrorist attack upon the United States, or any of its territories, possessions, or diplomatic or consular offices or upon any military
installation, asset, equipment or personnel of the United States, (iii) changes, events, occurrences or developments in, or effects or
results arising from or relating to, financial, banking, or securities markets (including any disruption of any of the foregoing markets,
any change in currency exchange rates, and any decline or rise in the price of any security, commodity, contract or index), (iv) changes
in, or effects arising from or relating to, any earthquake, hurricane, tsunami, tornado, flood, mudslide or other natural disaster, pandemic
(including COVID-19), weather condition, explosion or fire or other force majeure event or act of God, or (v) any change in, or effect
arising from or related to changes in, GAAP or other accounting requirements or principles or the interpretation thereof.

 

    2 

     

    

 

3.2 Power.
The Company has all requisite limited liability company power to issue the Preferred Shares and Warrants and to execute and deliver this
Agreement, the Designation, the Warrants and the other instruments, documents and agreements being entered into at the Closing (each
a “Subscription Document” and collectively, the “Subscription Documents”) and to carry out and
perform its obligations under the terms of the Subscription Documents.

 

3.3 Subsidiaries.
Section 3.3 of the Disclosure Schedule sets forth a true and correct description of all of the Company’s Subsidiaries and the capitalization
thereof (including options, warrants and other such equity). For purposes of this Agreement, the term “Subsidiary”
means, with respect to the Company, any corporation or other entity of which at least a majority of the outstanding shares of stock or
other ownership interests having by the terms thereof ordinary voting power to elect a majority of the board of directors (or persons
performing similar functions) of such corporation or entity (regardless of whether or not at the time, in the case of a corporation,
stock of any other class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency)
is at the time directly or indirectly owned or controlled by the Company or one or more of its Affiliates and the term “Affiliate”
means, as to any person (the “Subject Person”), any other person that directly or indirectly through one or more intermediaries
controls or is controlled by, or is under direct or indirect common control with, the Subject Person. For the purposes of this definition,
“control” when used with respect to any person means the power to direct the management and policies of such person, directly
or indirectly, whether through the ownership of voting securities, through representation on such person’s board of directors or
other management committee or group, by contract or otherwise. All references contained herein to the terms Subsidiary or Affiliate,
shall be applicable to all Subsidiaries and Affiliates whether they existed as of the date hereof or were created, acquired, or otherwise
came to be included in the foregoing terms subsequent to the date hereof.

 

    3 

     

    

 

3.4 Authorization.
All limited liability company action on the part of the Company, its directors and its shareholders necessary for the authorization of
the Subscription Documents and the execution, delivery and performance of all obligations of the Company under the Subscription Documents,
including the issuance and delivery of the Preferred Shares, the Warrants, and the reservation of the Common Shares issuable upon conversion
of the Preferred Shares and upon exercise of the Warrant (collectively, the “Underlying Securities”) has been taken
or will be taken prior to the issuance of such Underlying Securities. The Subscription Documents, when executed and delivered by the
Company, shall constitute valid and binding obligations of the Company enforceable in accordance with their terms, subject to laws of
general application relating to bankruptcy, insolvency, the relief of debtors and, with respect to rights to indemnity, subject to federal
and state securities laws. The Underlying Securities, when issued in compliance with the provisions of the Subscription Documents, will
be validly issued, fully paid and non-assessable and free of any lien, pledge, mortgage, deed of trust, security interest, charge, claim,
easement, encroachment or other similar encumbrance (“Lien”) and issued in compliance with all applicable federal
and securities laws.

 

3.5 Governmental
Consents. Neither the Company nor any Subsidiary is required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other foreign, federal, state, local or other governmental authority or other
person in connection with the execution, delivery and performance by the Company of the Subscription Documents, other than (a) applicable
Blue Sky filings, (b) such as have already been obtained or such exemptive filings as are required to be made under applicable securities
laws, (c) such other filings that have been made pursuant to applicable state securities laws and post-sale filings pursuant to applicable
state and federal securities laws which the Company undertakes to file within the applicable time periods. Subject to the accuracy of
the representations and warranties of the Purchaser set forth in Section 4 hereof, the Company has taken all action necessary to exempt:
(i) the issuance and sale of the Units, (ii) the issuance of the Underlying Securities upon due conversion of the Preferred Shares and
due exercise of the Warrant, and (iii) the other transactions contemplated by the Subscription Documents from the provisions of any preemptive
rights, stockholder rights plan or other “poison pill” arrangement, any anti-takeover, business combination or control share
law or statute binding on the Company or to which the Company or any of its assets and properties may be subject and any provision of
the Company’s certificate of formation, operating agreement, or other organizational documentation, as the case may be, that is
or could reasonably be expected to become applicable to the Purchaser as a result of the transactions contemplated hereby, including
without limitation, the issuance of the Preferred Shares, the Warrants and the Underlying Securities (collectively, the “Securities”)
and the ownership, disposition or voting of the Securities by the Purchaser or the exercise of any right granted to the Purchaser pursuant
to this Agreement or the other Subscription Documents.

 

3.6 Compliance
with Laws. Neither the Company nor any Subsidiary is in violation of any applicable statute, rule, regulation, order or restriction
of any domestic or foreign government or any instrumentality or agency thereof in respect of the conduct of its business or the ownership
of its properties, which violation would have a Material Adverse Effect on the Company.

 

    4 

     

    

 

3.7 Compliance
with Other Instruments. Neither the Company nor any of its Subsidiaries is in violation or default of any term of its organizational
documents, or of any provision of any mortgage, indenture or contract to which it is a party and by which it is bound or of any judgment,
decree, order or writ, other than such violations that would not individually or in the aggregate have a Material Adverse Effect on the
Company. The execution, delivery and performance of the Subscription Documents, and the consummation of the transactions contemplated
by the Subscription Documents will not result in any such violation or be in conflict with, or constitute, with or without the passage
of time and giving of notice, either a default under any such provision, instrument, judgment, decree, order or writ or an event that
results in the creation of any Lien upon any assets of the Company or the suspension, revocation, impairment, forfeiture, or nonrenewal
of any material permit, license, authorization or approval applicable to the Company or any of its Subsidiaries, its business or operations
or any of its assets or properties. The sale of the Preferred Shares, the issuance of the Warrant and the subsequent issuance of the
Underlying Securities are not and will not be subject to any preemptive rights or rights of first refusal that have not been properly
waived or complied with.

 

3.8 Offering.
Assuming the accuracy of the representations and warranties of the Purchaser contained in Section 4 hereof, the offer, issue, and sale
of Securities are and will be exempt from the registration and prospectus delivery requirements of the Securities Act, and have been
registered or qualified (or are exempt from registration and qualification) under the registration, permit, or qualification requirements
of all applicable state securities laws. No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the
Securities Act (a “Disqualification Event”) is applicable to the Company or, to the Company’s knowledge, any
person listed in the first paragraph of Rule 506(d)(1) of the Securities Act, except for a Disqualification Event as to which Rule 506(d)(2)(ii)–(iv)
or (d)(3), is applicable.

 

3.9 Capitalization.
The Company has authorized shares as set forth in Section 3.9 of the Disclosure Schedule. All outstanding shares of capital stock are
duly authorized, validly issued, fully paid and non-assessable and have been issued in compliance with all applicable securities laws.
Except for the Securities or as otherwise listed in Section 3.9 of the Disclosure Schedule, there are no outstanding options, warrants,
script rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any person any right to subscribe for or acquire, any Common Shares, or contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional Common
Shares, or securities or rights convertible or exchangeable into shares of common stock. Except as set forth in Section 3.9 of the Disclosure
Schedule, there are no price based anti-dilution or price adjustment provisions contained in any security issued by the Company (or in
any agreement providing rights to security holders) and the issue and sale of the Securities will not obligate the Company to issue shares
or other securities to any person (other than the Purchaser) and will not result in a right of any holder of the Company’s securities
to adjust the exercise, conversion, exchange or reset price under such securities. Except as set forth in Section 3.9 of the Disclosure
Schedule, the Company owns, directly or indirectly, all of the capital stock of each Subsidiary free and clear of any Liens, and all
the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free
of preemptive and similar rights.

 

    5 

     

    

 

3.10 SEC
Reports; Financial Statements. The Company has filed all reports and registration statements required to be filed by it under the
Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including pursuant to Section
13(a) or 15(d) of the Exchange Act, for the two years preceding the date hereof (or such shorter period as the Company was required by
law to file such material) (the foregoing materials, including the exhibits thereto, being collectively referred to herein as the “SEC
Reports” and, together with the Disclosure Schedule to this Agreement, the “Disclosure Materials”). As of
their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC
Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC or OTC Markets
as applicable, with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with
generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except
as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not
contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

3.11 Material
Changes. Except as set forth in the SEC Reports, since the date of the latest financial statements, (a) there has been no event,
occurrence or development that, individually or in the aggregate, has had or that could result in a Material Adverse Effect, (b) the
Company has not incurred any liabilities (contingent or otherwise) other than (i) trade payables, accrued expenses and other liabilities
incurred in the ordinary course of business consistent with past practice and (ii) liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or required to be disclosed in filings made with the SEC, (c) the Company has not altered its method
of accounting or the identity of its auditors, (d) the Company has not declared or made any dividend or distribution of cash or other
property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its shares, and (e) the
Company has not issued any equity securities to any officer, director or affiliate, except pursuant to existing Company stock-based plans
or agreements.

 

3.12 Litigation.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”)
which: (a) adversely affects or challenges the legality, validity or enforceability of any of the Subscription Documents or the Securities
or (b) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the
Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation
of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge
of the Company, there is not pending or contemplated, any investigation by governmental authority, or any litigation civil or otherwise,
involving the Company or any current or former director or officer of the Company or its Subsidiaries.

 

    6 

     

    

 

3.13 Labor
Relations. Neither the Company nor any Subsidiary is a party to or bound by any collective bargaining agreements or other agreements
with labor organizations. Neither the Company nor any Subsidiary has violated in any material respect any laws, regulations, orders or
contract terms, affecting the collective bargaining rights of employees, labor organizations or any laws, regulations or orders affecting
employment discrimination, equal opportunity employment, or employees’ health, safety, welfare, wages and hours. No material labor
dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company which could reasonably
be expected to result in a Material Adverse Effect.

 

3.14 Regulatory
Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses, except where the failure to possess
such permits would not have or reasonably be expected to result in a Material Adverse Effect (“Material Permits”),
and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material
Permit.

 

3.15 Title
to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them that
is material to the business of the Company and the Subsidiaries and good and marketable title in all personal property owned by them
that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for Liens as do
not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property
by the Company and the Subsidiaries and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases of which the Company and the Subsidiaries are in compliance.

 

3.16 Taxes.

 

(a) The
Company and its Subsidiaries have timely and properly filed all tax returns required to be filed by them for all years and periods (and
portions thereof) for which any such tax returns were due, except where the failure to so file would not have a Material Adverse Effect;
all such filed tax returns are accurate in all material respects; the Company has timely paid all taxes due and payable (whether or not
shown on filed tax returns), except where the failure to so pay would not have a Material Adverse Effect; there are no pending assessments,
asserted deficiencies or claims for additional taxes that have not been paid; the reserves for taxes, if any, reflected in the financial
statements are adequate, and there are no Liens for taxes on any property or assets of the Company and any of its Subsidiaries (other
than Liens for taxes not yet due and payable); there have been no audits or examinations of any tax returns by any (i) nation, state,
commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (ii) federal, state, local, municipal,
foreign or other government; or (iii) governmental or quasi-governmental authority of any nature (including any governmental or administrative
division, department, agency, commission, instrumentality, official, organization, unit, body or entity) and any court or other tribunal
(a “Governmental Body”), and the Company or its Subsidiaries have not received any notice that such audit or examination
is pending or contemplated; no claim has been made by any Governmental Body in a jurisdiction where the Company or any of its Subsidiaries
does not file tax returns that it is or may be subject to taxation by that jurisdiction; to the knowledge of the Company, no state of
facts exists or has existed which would constitute grounds for the assessment of any penalty or any further tax liability beyond that
shown on the respective tax returns; and there are no outstanding agreements or waivers extending the statutory period of limitation
for the assessment or collection of any tax.

 

    7 

     

    

 

(b) Neither
the Company nor any of its Subsidiaries is a party to any tax-sharing agreement or similar arrangement with any other Person.

 

(c) The
Company has made all necessary disclosures required by Treasury Regulation Section 1.6011-4. The Company has not been a participant in
a “reportable transaction” within the meaning of Treasury Regulation Section 1.6011-4(b).

 

(d) No
payment or benefit paid or provided, or to be paid or provided, to current or former employees, directors or other service providers
of the Company will fail to be deductible for federal income tax purposes under Section 280G of the Internal Revenue Code of 1986, as
amended (the “Code”).

 

3.17 Patents
and Trademarks. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, copyrights, licenses and other similar rights that are necessary or material for use in connection
with their respective businesses and which the failure to so have could have or reasonably be expected to result in a Material Adverse
Effect (collectively, the “Intellectual Property Rights”). Neither the Company nor any Subsidiary has received a written
notice that the Intellectual Property Rights used by the Company or any Subsidiary violates or infringes upon the rights of any Person.
All such Intellectual Property Rights are enforceable. The Company and its Subsidiaries have taken reasonable steps to protect the Company’s
and its Subsidiaries’ rights in their Intellectual Property Rights and confidential information (the “Confidential Information”).
Each employee, consultant and contractor who has had access to Confidential Information which is necessary for the conduct of the Company’s
and each of its Subsidiaries’ respective businesses as currently conducted or as currently proposed to be conducted has executed
an agreement to maintain the confidentiality of such Confidential Information and has executed appropriate agreements that are substantially
consistent with the Company’s standard forms thereof. Except under confidentiality obligations, there has been no material disclosure
of any of the Company’s or its Subsidiaries’ Confidential Information to any third party.

 

3.18 Environmental
Matters. Neither the Company nor any Subsidiary is in violation of any statute, rule, regulation, decision or order of any Governmental
Body relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment
or human exposure to hazardous or toxic substances (collectively, “Environmental Laws”), owns or operates any real
property contaminated with any substance that is subject to any Environmental Laws, is liable for any off-site disposal or contamination
pursuant to any Environmental Laws, or is subject to any claim relating to any Environmental Laws, which violation, contamination, liability
or claim has had or could reasonably be expected to have a Material Adverse Effect, individually or in the aggregate; and there is no
pending or, to the Company’s knowledge, threatened investigation that might lead to such a claim.

 

    8 

     

    

 

3.19 Insurance.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.

 

3.20 Transactions
with Affiliates and Employees. Except as disclosed in the Company’s audited financial statements or the Disclosure Materials,
none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company,
any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner,
other than (a) for payment of salary or consulting fees for services rendered, (b) reimbursement for expenses incurred on behalf of the
Company and (c) for other employee benefits, including stock option agreements under any stock option plan of the Company.

 

3.21 Brokers
and Finders. Except as otherwise itemized in Section 3.21 of the Disclosure Schedule, no person will have, as a result of the transactions
contemplated by the Subscription Documents, any valid right, interest or claim against or upon the Company, any Subsidiary or the Purchaser
for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of
the Company.

 

3.22 Questionable
Payments. Neither the Company nor any of its Subsidiaries nor, to the Company’s knowledge, any of their respective current
or former stockholders, directors, officers, employees, agents or other persons acting on behalf of the Company or any Subsidiary, has
on behalf of the Company or any Subsidiary or in connection with their respective businesses: (a) used any corporate funds for unlawful
contributions, gifts, entertainment or other unlawful expenses relating to political activity; (b) made any direct or indirect unlawful
payments to any governmental officials or employees from corporate funds; (c) established or maintained any unlawful or unrecorded fund
of corporate monies or other assets; (d) made any false or fictitious entries on the books and records of the Company or any Subsidiary;
or (e) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment of any nature.

 

3.23 Solvency.
The Company has not (a) made a general assignment for the benefit of creditors; (b) filed any voluntary petition in bankruptcy or suffered
the filing of any involuntary petition by its creditors; (c) suffered the appointment of a receiver to take possession of all, or substantially
all, of its assets; (d) suffered the attachment or other judicial seizure of all, or substantially all, of its assets; (e) admitted in
writing its inability to pay its debts as they come due; or (f) made an offer of settlement, extension or composition to its creditors
generally.

 

    9 

     

    

 

3.24 Foreign
Corrupt Practices Act. None of the Company or any of its Subsidiaries, nor to the knowledge of the Company, any agent or other person
acting on behalf of the Company or any of its Subsidiaries, has, directly or indirectly: (a) used any funds, or will use any proceeds
from the sale of the Securities, for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic
political activity, (b) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic
political parties or campaigns from corporate funds, (c) failed to disclose fully any contribution made by the Company or any of its
Subsidiaries (or made by any person acting on their behalf of which the Company is aware) or any members of their respective management
which is in violation of any legal requirement, or (d) has violated in any material respect any provision of the Foreign Corrupt Practices
Act of 1977, as amended, and the rules and regulations thereunder which was applicable to the Company or any of its Subsidiaries.

 

3.25 Disclosures.
Neither the Company nor any person acting on its behalf has provided the Purchaser or its agents or counsel with any information that
constitutes or might constitute material, non-public information, other than the terms of the transactions contemplated hereby. The written
materials delivered to the Purchaser in connection with the transactions contemplated by the Subscription Documents do not contain any
untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein, in
light of the circumstances under which they were made, not misleading.

 

3.26 Transfer
Agent. The Company represents and warrants that it will not replace its transfer agent without the Purchaser’s permission so
long as any of the Preferred Shares are outstanding. The Company acknowledges that any failure to comply with this Section shall constitute
a material breach of this Agreement.

 

3.27 Shell
Company Status. As of March 3, 2017, the Company ceased to be a Shell Company as defined in paragraph (i)(1)(i) of Rule 144.

 

3.28 Notice
of Developments. The Company agrees and acknowledges that so long as any obligations of the Company under any of the Subscription
Documents shall exist, it shall be obligated to provide notice to the Purchaser in the event of a material change to any representation
or disclosure in any of the Subscription Documents, including but not limited to, the disclosures on the Disclosure Schedule, which notice
shall be deemed to have been given to the Purchaser if the Company discloses such information through a report or other filing by the
Company with the Securities and Exchange Commission, and failure to provide such notice shall constitute a material breach of this Agreement
and an Event of Default under the Designation.

 

		4.	REPRESENTATIONS
                                            AND WARRANTIES OF THE PURCHASER

 

4.1 Purchase
for Own Account. The Purchaser represents that it is acquiring the Units for its own account and not with the view to transfer the
Units or otherwise distribute them except in compliance with the Securities Act.

 

    10 

     

    

 

4.2 Information
and Sophistication. Without lessening or obviating the representations and warranties of the Company set forth in Section 3, the
Purchaser hereby: (a) acknowledges that it has received all the information it has requested from the Company that it considers necessary
or appropriate for deciding whether to acquire the Units, (b) represents that it has had an opportunity to ask questions and receive
answers from the Company regarding the terms and conditions of the offering of the Units and to obtain any additional information necessary
to verify the accuracy of the information given the Purchaser and (c) further represents that it has such knowledge and experience in
financial and business matters that it is capable of evaluating the merits and risk of this investment.

 

4.3 Ability
to Bear Economic Risk. The Purchaser acknowledges that investment in the Units involves a high degree of risk, and represents that
it is able, without materially impairing its financial condition, to hold the Units for an indefinite period of time and to suffer a
complete loss of its investment.

 

4.4 Accredited
Investor Status. The Purchaser is an “accredited investor” as such term is defined in Rule 501 under the Securities Act.

 

4.5 Existence;
Authorization. The Purchaser is an individual, corporation, partnership or limited liability company duly organized, validly existing
and in good standing under the laws of the state of its organization, having full power and authority to own its properties and to carry
on its business as conducted. The principal place of business of the Purchaser is as shown on the Accredited Investor Questionnaire.
The Purchaser has the requisite power and authority to deliver this Agreement, perform its obligations set forth herein, and consummate
the transactions contemplated hereby. The Purchaser has duly executed and delivered this Agreement and has obtained the necessary authorization
to execute and deliver this Agreement and to perform his, her or its obligations herein and to consummate the transactions contemplated
hereby. This Agreement, assuming the due execution and delivery hereof by the Company, is a legal, valid and binding obligation of the
Purchaser enforceable against the Purchaser in accordance with its terms.

 

4.6 No
Regulatory Approval. The Purchaser understands that no state or federal authority has scrutinized this Agreement or the Units offered
pursuant hereto, has made any finding or determination relating to the fairness for investment in the Units, or has recommended or endorsed
the Units, and that the Units have not been registered or qualified under the Securities Act or any state securities laws, in reliance
upon exemptions from registration thereunder. The Units may not, in whole or in part, be resold, transferred, assigned or otherwise disposed
of unless they are registered under the Securities Act or an exemption from registration is available, and unless the proposed disposition
is in compliance with the restrictions on transferability under federal and state securities laws.

 

4.7 Purchaser
Received Independent Advice. The Purchaser confirms that the Purchaser has been advised to consult with the Purchaser’s independent
attorney regarding legal matters concerning the Company and to consult with independent tax advisers regarding the tax consequences of
investing in the Company. The Purchaser acknowledges that Purchaser understands that any anticipated United States federal or state income
tax benefits may not be available and, further, may be adversely affected through adoption of new laws or regulations or amendments to
existing laws or regulations. The Purchaser acknowledges and agrees that the Company is providing no warranty or assurance regarding
the ultimate availability of any tax benefits to the Purchaser by reason of the subscription.

 

    11 

     

    

 

4.8 Agreement
to be Bound by Operating Agreement. The Purchaser acknowledges receipt of a true and correct copy of the Second Amended and Restated
Operating Agreement of the Company, dated January 19, 2018 (as such may be amended, modified or restated from time to time, the “Operating
Agreement”), and further acknowledges that Purchaser has read the Operating Agreement and understands and agrees to abide by
all terms, covenants, conditions, limitations, restrictions and provisions contained in the Operating Agreement. By execution of this
Agreement, the Purchaser agrees to be bound by the Operating Agreement and agrees that the Operating Agreement is binding upon and inures
to the benefit of the heirs, legatees, devisees, legal representatives, successors and permitted assigns of the Purchaser.

 

4.9 Legends.
The Purchaser understands that until such time as the Preferred Shares, Warrants, and, upon the conversion of the Preferred Shares and
the exercise of the Warrants in accordance with its respective terms, the Underlying Securities, have been registered under the Securities
Act or may be sold pursuant to Rule 144, Rule 144A under the Securities Act or Regulation S without any restriction as to the number
of securities as of a particular date that can then be immediately sold, the Securities may bear a restrictive legend in substantially
the following form (and a stop-transfer order may be placed against transfer of the certificates for such Securities):

 

“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE
OR EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES
MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE PURCHASER), IN A GENERALLY
ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S
UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN
OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

		5.	FURTHER
                                            AGREEMENTS; POST-CLOSING COVENANTS

 

5.1 Use
of Proceeds. Assuming that the full $1,750,000 is raised in the Offering, the Company shall use the proceeds from the Offering solely
for working capital and general corporate purposes, including the satisfaction of outstanding liabilities and the payment of transaction
expenses in connection with the Offering.

 

5.2 Form
D; Blue Sky Laws. The Company agrees to file a Form D with respect to the Units as required under Regulation D and to provide a copy
thereof to the Purchaser promptly after such filing. The Company shall take such action as the Company shall reasonably determine is
necessary to qualify the Securities for sale to the Purchaser at the applicable closing pursuant to this Agreement under applicable securities
or “blue sky” laws of the states of the United States (or to obtain an exemption from such qualification), and shall provide
evidence of any such action so taken to the Purchaser on or prior to the initial Closing.

 

    12 

     

    

 

5.3 Registration
Rights.

 

(a) Mandatory
Registration. The Company shall prepare, and, as soon as practicable but in no event later than thirty (30) days after the Closing
Date (the “Filing Deadline”), file with the SEC a Registration Statement under the Securities Act on appropriate form
covering the resale of the full amount of the Underlying Securities (collectively, the “Registrable Securities”).
The Company shall use its commercially reasonable efforts to have the Registration Statement declared effective by the SEC as soon as
practicable, but in no event later than the date (the “Effectiveness Deadline”), which shall be either (i) in the
event that the SEC does not review the Registration Statement, ninety (90) days after the Closing Date, or (ii) in the event that the
SEC reviews the Registration Statement, one hundred fifty (150) days after the Closing Date (but in any event, no later than two (2)
Business Days from the SEC indicating that it has no further comments on the Registration Statement).

 

(b) Limitation
on Registrable Securities. In the event that the staff of the SEC (the “Staff”) determines that the full amount
of the Registrable Securities cannot be registered on the Registration Statement due to limitations under Rule 415 of the Securities
Act, then the Company shall: (i) register the resale of that portion of the Registrable Securities as the Staff may permit under its
interpretations of Rule 415, and (ii) undertake to register the remaining portion of the Registrable Securities as soon as registration
would be permitted under Rule 415, as determined by the Company in good faith based on the Staff’s publicly available interpretations
of Rule 415.

 

(c) Related
Obligations. At such time as the Company is obligated to file a Registration Statement with the SEC pursuant to Section 5.3(a) hereof,
the Company will use commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with the
intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:

 

(i) The
Company shall submit to the SEC, within two (2) Business Days after the Company learns that no review of a particular Registration Statement
will be made by the staff of the SEC or that the staff has no further comments on a particular Registration Statement, as the case may
be, a request for acceleration of effectiveness of such Registration Statement to a time and date not later than two (2) Business Days
after the submission of such request. The Company shall keep each Registration Statement effective pursuant to Rule 415 at all times
until the earlier of (A) the date as of which the Purchaser may sell all of the Registrable Securities covered by such Registration Statement
without restriction or limitation pursuant to Rule 144 and without the requirement to be in compliance with Rule 144(c)(1) (or any successor
thereto) promulgated under the Securities Act or (B) the date on which the Purchaser shall have sold all of the Registrable Securities
covered by such Registration Statement (the “Registration Period”). The Company shall ensure that each Registration
Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein (in the
case of prospectuses, in the light of the circumstances in which they were made) not misleading.

 

    13 

     

    

 

(ii) The
Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to a Registration Statement
and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424 promulgated
under the Securities Act, as may be necessary to keep such Registration Statement effective at all times during the Registration Period,
and, during such period, comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities
of the Company covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed
of in accordance with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement.

 

(iii) The
Company shall furnish to the Purchaser without charge, (A) promptly after the Registration Statement including the Purchaser’s
Registrable Securities is prepared and filed with the SEC, at least one copy of such Registration Statement and any amendment(s) thereto,
including financial statements and schedules, all documents incorporated therein by reference, if requested by the Purchaser, all exhibits
and each preliminary prospectus, (B) upon the effectiveness of any Registration Statement, ten (10) copies of the prospectus included
in such Registration Statement and all amendments and supplements thereto (or such other number of copies as the Purchaser may reasonably
request) and (C) such other documents, including copies of any preliminary or final prospectus, as the Purchaser may reasonably request
from time to time in order to facilitate the disposition of the Registrable Securities.

 

(iv) The
Company shall notify the Purchaser in writing of the happening of any event, as promptly as practicable after becoming aware of such
event, as a result of which the prospectus included in a Registration Statement, as then in effect, includes an untrue statement of a
material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material,
nonpublic information), and, promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement
or omission, and deliver ten (10) copies of such supplement or amendment to the Purchaser (or such other number of copies as the Purchaser
may reasonably request). The Company shall also promptly notify the Purchaser in writing (A) when a prospectus or any prospectus supplement
or post- effective amendment has been filed, and when a Registration Statement or any post- effective amendment has become effective
(notification of such effectiveness shall be delivered to the Purchaser by facsimile on the same day of such effectiveness and by overnight
mail), (B) of any request by the SEC for amendments or supplements to a Registration Statement or related prospectus or related information,
and (iii) of the Company’s reasonable determination that a post-effective amendment to a Registration Statement would be appropriate.

 

    14 

     

    

 

(v) The
Company shall use commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of a
Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction and,
if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to
notify the Purchaser who holds Registrable Securities being sold of the issuance of such order and the resolution thereof or its receipt
of notice of the initiation or threat of any proceeding for such purpose.

 

(vi) If
the Purchaser is required under applicable securities law to be described in the Registration Statement as an underwriter, at the reasonable
request of the Purchaser, the Company shall furnish to the Purchaser, on the date of the effectiveness of the Registration Statement
and thereafter from time to time on such dates as the Purchaser may reasonably request (A) a letter, dated such date, from the Company’s
independent certified public accountants in form and substance as is customarily given by independent certified public accountants to
underwriters in an underwritten public offering, addressed to the Purchaser, and (B) an opinion, dated as of such date, of counsel representing
the Company for purposes of such Registration Statement, in form, scope and substance as is customarily given in an underwritten public
offering, addressed to the Purchaser.

 

(vii) If
the Purchaser is required under applicable securities law to be described in the Registration Statement as an underwriter, upon the written
request of the Purchaser in connection with the Purchaser’s due diligence requirements, if any, the Company shall make available
for inspection by (A) the Purchaser and its legal counsel and (B) one firm of accountants or other agents retained by the Purchaser (collectively,
the “Inspectors”), all pertinent financial and other records, and pertinent corporate documents and properties of
the Company (collectively, the “Records”), as shall be reasonably deemed necessary by each Inspector solely for the
purpose of establishing a due diligence defense under underwriter liability under the Securities Act, and cause the Company’s officers,
directors and employees to supply all information which any Inspector may reasonably request; provided, however, that each Inspector
shall agree to hold in strict confidence and shall not make any disclosure (except to the Purchaser) or use of any Record or other information
which the Company determines in good faith to be confidential, and of which determination the Inspectors are so notified, unless (1)
the disclosure of such Records is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise
required under the Securities Act, (2) the release of such Records is ordered pursuant to a final, non-appealable subpoena or order from
a court or government body of competent jurisdiction, or (3) the information in such Records has been made generally available to the
public other than by disclosure in violation of this or any other Transaction Document. The Purchaser agrees that it shall, upon learning
that disclosure of such Records is sought in or by a court or governmental body of competent jurisdiction or through other means, give
prompt notice to the Company and allow the Company, at its expense, to undertake appropriate action to prevent disclosure of, or to obtain
a protective order for, the Records deemed confidential. Nothing herein (or in any other confidentiality agreement between the Company
and the Purchaser) shall be deemed to limit the Purchaser’s ability to sell Registrable Securities in a manner which is otherwise
consistent with applicable laws and regulations.

 

    15 

     

    

 

(viii) The
Company shall hold in confidence and not make any disclosure of information concerning the Purchaser provided to the Company unless (A)
disclosure of such information is necessary to comply with federal or state securities laws, (B) the disclosure of such information is
necessary to avoid or correct a misstatement or omission in any Registration Statement, (C) the release of such information is ordered
pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction or (D) such information
has been made generally available to the public other than by disclosure in violation of this Agreement or any other agreement. The Company
agrees that it shall, upon learning that disclosure of such information concerning the Purchaser is sought in or by a court or governmental
body of competent jurisdiction or through other means, give prompt written notice to the Purchaser and allow the Purchaser, at the Purchaser’s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.

 

(ix) The
Company shall cooperate with the Purchaser and, to the extent applicable, facilitate the timely preparation and delivery of certificates
(not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable
such certificates to be in such denominations or amounts, as the case may be, as the Purchaser may reasonably request and registered
in such name as the Purchaser may request.

 

(x) If
requested by the Purchaser, the Company shall (A) as soon as practicable incorporate in a prospectus supplement or post-effective amendment
such information as the Purchaser reasonably requests to be included therein relating to the sale and distribution of Registrable Securities,
including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price
being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (B) as soon as practicable
make all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated
in such prospectus supplement or post-effective amendment; and (C) as soon as practicable, supplement or make amendments to any Registration
Statement if reasonably requested by the Purchaser.

 

(xi) The
Company shall use commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to be registered
with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.

 

(xii) The
Company shall otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC in connection
with any registration hereunder.

 

    16 

     

    

 

(xiii) Within
two (2) Business Days after a Registration Statement that covers Registrable Securities is ordered effective by the SEC, the Company
shall deliver to the transfer agent for such Registrable Securities (with copies to the Purchaser) confirmation that such Registration
Statement has been declared effective by the SEC.

 

(xiv) Notwithstanding
anything to the contrary herein, at any time after the Effective Date, the Company may delay the disclosure of material, non-public information
concerning the Company the disclosure of which at the time is not, in the good faith opinion of the Board of Directors and its counsel,
in the best interest of the Company and, in the opinion of counsel to the Company, otherwise required (a “Grace Period”);
provided, that the Company shall promptly (A) notify the Purchaser in writing of the existence of material, non-public information giving
rise to a Grace Period (provided that in each notice the Company will not disclose the content of such material, non-public information
to the Purchaser) and the date on which the Grace Period will begin, and (B) notify the Purchaser in writing of the date on which the
Grace Period ends; and, provided further, that the Grace Periods shall not exceed an aggregate of thirty (30) Trading Days during any
365-day period and the first day of any Grace Period must be at least fifteen (15) days after the last day of any prior Grace Period
(each, an “Allowable Grace Period”). For purposes of determining the length of a Grace Period above, the Grace Period
shall begin on and include the date the Purchaser receives the notice referred to in clause (A) and shall end on and include the later
of the date the Purchaser receives the notice referred to in clause (B) and the date referred to in such notice. The provisions of Section
5.3(c)(v) hereof shall not be applicable during the period of any Allowable Grace Period. Upon expiration of the Grace Period, the Company
shall again be bound by the first sentence of Section 5.3(c)(iv) with respect to the information giving rise thereto unless such material,
non-public information is no longer applicable. Notwithstanding anything to the contrary, the Company shall cause its transfer agent
to deliver unlegended Common Shares to a transferee of any Purchaser in accordance with the terms of this Agreement in connection with
any sale of Registrable Securities with respect to which a Purchaser has entered into a contract for sale, and delivered a copy of the
prospectus included as part of the applicable Registration Statement (unless an exemption from such prospectus delivery requirement exists),
prior to the Purchaser’s receipt of the notice of a Grace Period and for which the Purchaser has not yet settled.

 

(xv) Neither
the Company nor any Subsidiary or affiliate thereof shall identify the Purchaser as an underwriter in any public disclosure or filing
with the SEC or any applicable Trading Market and the Purchaser being deemed an underwriter by the SEC shall not relieve the Company
of any obligations it has under this Agreement and any other documents or instruments executed and delivered in connection with the Agreement.

 

(d) Obligations
of the Purchaser.

 

(i) At
least five (5) Business Days prior to the first anticipated filing date of a Registration Statement, the Company shall notify the Purchaser
in writing of the information the Company requires from the Purchaser in order to have that Purchaser’s Registrable Securities
included in such Registration Statement. It shall be a condition precedent to the obligations of the Company to complete the registration
pursuant to this Agreement with respect to the Registrable Securities of a particular Purchaser that the Purchaser shall furnish to the
Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable
Securities held by it as shall be reasonably required to effect the effectiveness of the registration of such Registrable Securities
and shall execute such documents in connection with such registration as the Company may reasonably request.

 

    17 

     

    

 

(ii) Each
Purchaser, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of any Registration Statement hereunder, unless the Purchaser has notified the Company
in writing of the Purchaser’s election to exclude all of the Purchaser’s Registrable Securities from such Registration Statement.

 

(iii) Each
Purchaser agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 5.3(c)(v)
or the first sentence of Section 5.3(c)(iv), the Purchaser will immediately discontinue disposition of Registrable Securities pursuant
to any Registration Statement(s) covering such Registrable Securities until the Purchaser’s receipt of the copies of the supplemented
or amended prospectus contemplated by Section 5.3(c)(v) or the first sentence of Section 5.3(c)(iv) or receipt of notice that no supplement
or amendment is required. Notwithstanding anything to the contrary, the Company shall cause its transfer agent to deliver unlegended
Common Shares to a transferee of the Purchaser in accordance with the terms of this Agreement in connection with any sale of Registrable
Securities with respect to which the Purchaser has entered into a contract for sale prior to the Purchaser’s receipt of a notice
from the Company of the happening of any event of the kind described in Section 5.3(c)(v) or the first sentence of Section 5.3(c)(iv)
and for which the Purchaser has not yet settled.

 

(iv) Each
Purchaser covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it
or an exemption therefrom in connection with sales of Registrable Securities pursuant to the Registration Statement.

 

(e) Expenses
of Registration. All reasonable expenses, other than underwriting discounts and commissions incurred in connection with registrations,
filings or qualifications pursuant to Section 5.3, including, without limitation, all registration, listing and qualifications fees,
printers and accounting fees, and fees and disbursements of counsel for the Company, shall be paid by the Company.

 

(f) Reports
under the Exchange Act. With a view to making available to the Purchaser the benefits of Rule 144 promulgated under the Securities
Act or any other similar rule or regulation of the SEC that may at any time permit the Purchaser to sell securities of the Company to
the public without registration (“Rule 144”), the Company agrees to:

 

(i) make
and keep public information available, as those terms are understood and defined in Rule 144, during the Reporting Period;

 

    18 

     

    

 

(ii) file
with the SEC in a timely manner all reports and other documents required of the Company under the Exchange Act; and

 

(iii) furnish
to the Purchaser so long as the Purchaser owns Registrable Securities, promptly upon request during the Reporting Period, (A) a written
statement by the Company, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange
Act, (B) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company
and (C) such other information as may be reasonably requested to permit the Purchaser to sell such securities pursuant to Rule 144 without
registration.

 

(g) Assignment
of Registration Rights. The rights under Section 5.3 shall be automatically assignable by a Purchaser to any transferee of all or
any portion of the Purchaser’s Registrable Securities if: (i) the Purchaser agrees in writing with the transferee or assignee to
assign such rights and a copy of such agreement is furnished to the Company within a reasonable time after such assignment; (ii) the
Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (A) the name and address of
such transferee or assignee and (B) the securities with respect to which such registration rights are being transferred or assigned;
(iii) immediately following such transfer or assignment the further disposition of such securities by the transferee or assignee is restricted
under the Securities Act or applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated
by clause (ii) of this sentence the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained
herein; and (v) such transfer shall have been made in accordance with the applicable requirements of this Agreement.

 

(h) Indemnification.

 

(i) Company
Indemnification. The Company will indemnify the Purchaser (if Registrable Securities held by the Purchaser are included in the securities
as to which such registration is being effected), each of its officers and directors, partners, members and each person controlling the
Purchaser within the meaning of Section 15 of the Securities Act, against all expenses, claims, losses, damages or liabilities (or actions
in respect thereof), including any of the foregoing incurred in settlement of any litigation, commenced or threatened, arising out of
or based on (A) any untrue statement (or alleged untrue statement) of a material fact contained in any Registration Statement, prospectus,
offering circular or other document, or any amendment or supplement thereto, incident to any such Registration Statement, or based on
any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading, or (B) any violation by the Company of the Securities
Act, the Exchange Act, state securities laws or any rule or regulation promulgated under such laws applicable to the Company in connection
with any such registration, and in each case, the Company will reimburse the Purchaser, each of its officers and directors, partners,
members and each person controlling the Purchaser, for any legal and any other expenses reasonably incurred, as such expenses are incurred,
in connection with investigating, preparing or defending any such claim, loss, damage, liability or action, provided that the Company
will not be liable in any such case to the extent that any such claim, loss, damage, liability or expense arises out of or is based on
(x) any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information
furnished to the Company by an instrument duly executed by the Purchaser or controlling person, and stated to be specifically for use
therein, (y) the use by a Purchaser of an outdated or defective prospectus after the Company has notified the Purchaser in writing that
the prospectus is outdated or defective or (z) a Purchaser’s (or any other indemnified person’s) failure to send or give
a copy of the prospectus or supplement (as then amended or supplemented), if required, pursuant to Rule 172 under the Securities Act
(or any successor rule) to the Persons asserting an untrue statement or alleged untrue statement or alleged untrue statement or omission
or alleged omission at or prior to the written confirmation of the sale of Registrable Securities to such person if such statement or
omission was corrected in such prospectus or supplement; provided, further, that the indemnity agreement contained in this Section 5.3(h)(i)
shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without
the consent of the Company (which consent shall not be unreasonably withheld).

 

    19 

     

    

 

(ii) Purchaser
Indemnification. The Purchaser will, if Registrable Securities held by the Purchaser are included in the securities as to which such
registration is being effected, indemnify the Company, each of its directors and officers, other holders of the Company’s securities
covered by such Registration Statement, each person who controls the Company within the meaning of Section 15 of the Securities Act,
and each such holder, each of its officers and directors and each person controlling such holder within the meaning of Section 15 of
the Securities Act, against all claims, losses, damages and liabilities (or actions in respect thereof) arising out of or based on: (A)
any untrue statement (or alleged untrue statement) of a material fact contained in any such Registration Statement, prospectus, offering
circular or other document, or any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary
to make the statements therein not misleading, to the extent, and only to the extent, that such untrue statement (or alleged untrue statement)
or omission (or alleged omission) is made in such Registration Statement, prospectus, offering circular or other document in reliance
upon and in conformity with written information furnished to the Company by an instrument duly executed by the Purchaser and stated to
be specifically for use therein, or (B) any violation by the Purchaser of the Securities Act, the Exchange Act, state securities laws
or any rule or regulation promulgated under such laws applicable to the Purchaser, and in each case, the Purchaser will reimburse the
Company, each other holder, and directors, officers, persons, underwriters or control persons of the Company and the other holders for
any legal or any other expenses reasonably incurred, as such expenses are incurred, in connection with investigating or defending any
such claim, loss, damage, liability or action; provided, that the indemnity agreement contained in this Section 5.3(h)(ii) shall not
apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent
of such indemnifying Purchaser (which consent shall not be unreasonably withheld or delayed). The liability of any Purchaser for indemnification
under this Section 5.3(h)(ii) in its capacity as a seller of Registrable Securities shall not exceed the amount of net proceeds to the
Purchaser of the securities sold in any such registration.

 

    20 

     

    

 

(iii) Notice
and Procedure. Each party entitled to indemnification under this Section 5.3(h) (the “Indemnified Party”) shall
give written notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such
Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit the Indemnifying Party to assume
the defense of any such claim or any litigation resulting therefrom, provided that counsel for the Indemnifying Party, who shall conduct
the defense of such claim or litigation, shall be approved by the Indemnified Party (whose approval shall not unreasonably be withheld),
and the Indemnified Party may participate in such defense at such party’s expense, and provided further that the failure of any
Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Agreement
unless the failure to give such notice is materially prejudicial to an Indemnifying Party’s ability to defend such action and provided
further, that the Indemnifying Party shall not assume the defense for matters as to which there is a conflict of interest or there are
separate and different defenses. No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the consent
of each Indemnified Party (whose consent shall not be unreasonably withheld), consent to entry of any judgment or enter into any settlement
which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release
from all liability in respect to such claim or litigation.

 

(iv) Contribution.
If the indemnification provided for in this Section 5.3(h) is held by a court of competent jurisdiction to be unavailable to an Indemnified
Party with respect to any losses, claims, damages or liabilities referred to herein, the Indemnifying Party, in lieu of indemnifying
such Indemnified Party thereunder, shall to the extent permitted by applicable law contribute to the amount paid or payable by such Indemnified
Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the
Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the untrue statement or omission that
resulted in such loss, claim, damage or liability, as well as any other relevant equitable considerations. The relative fault of the
Indemnifying Party and of the Indemnified Party shall be determined by a court of law by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the
Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such statement or omission; provided, that in no event shall any contribution by a Purchaser hereunder exceed the
proceeds from the offering received by the Purchaser. The amount paid or payable by a party as a result of any loss, claim, damage or
liability shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other
reasonable fees or expenses incurred by such party in connection with any proceeding to the extent such party would have been indemnified
for such fees or expenses if the indemnification provided for in this Section 5.3(h) was available to such party in accordance with its
terms.

 

    21 

     

    

 

(v) Survival.
The obligations of the Company and the Purchaser under this Section 5.3(h) shall survive completion of any offering of Registrable Securities
in a Registration Statement and the termination of this Agreement. The indemnity and contribution agreements contained in this Section
5.3(h) are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties and are not in diminution or
limitation of other remedies or causes of action that the parties may have under the this Agreement and any other documents or instruments
executed and delivered in connection with the Agreement.

 

5.4 Legal
Counsel Opinions. Upon the request of the Purchaser from time to time, the Company shall be responsible (at its cost) for promptly
supplying to Company’s transfer agent and the Purchaser a customary legal opinion letter of its counsel (the “Legal Counsel
Opinion”) to the effect that the resale of the Underlying Securities by the Purchaser or its affiliates, successors and assigns
is exempt from the registration requirements of the Securities Act pursuant to Rule 144 (provided the requirements of Rule 144 are satisfied
and provided the Underlying Securities are not then registered under the Securities Act for resale pursuant to an effective registration
statement). Should the Company’s legal counsel fail for any reason to issue the Legal Counsel Opinion, the Purchaser may (at the
Company’s cost) secure another legal counsel to issue the Legal Counsel Opinion, and the Company will instruct its transfer agent
to accept such opinion. The Company shall not impede the removal by its stock transfer agent of the restricted legend from any common
stock certificate upon receipt by the transfer agent of a Rule 144 Opinion Letter. THE COMPANY HEREBY AGREES THAT IT MAY NEVER TAKE
THE POSITION THAT IT IS A “SHELL COMPANY” IN CONNECTION WITH ITS OBLIGATIONS UNDER THIS AGREEMENT OR OTHERWISE UNLESS THE
COMPANY HAS SOUGHT THE ADVICE OF ITS COUNSEL AND ITS COUNSEL HAS INDICATED THAT IT MUST TAKE SUCH POSITION AS A MATTER OF APPLICABLE
LAW

 

5.5 Listing.
The Company will, so long as the Purchaser owns any of the Securities, maintain the listing and trading of its Common Shares on the OTCQB
or any equivalent exchange or electronic quotation system or a national securities exchange and will comply in all respects with the
Company’s reporting, filing and other obligations under the bylaws or rules of the Financial Industry Regulatory Authority and
such exchanges, as applicable, as well as with the SEC. The Company shall promptly provide to the Purchaser copies of any notices it
receives from the OTCQB and any other exchanges or electronic quotation systems on which the Common Shares are then traded regarding
the continued eligibility of the common stock for listing on such exchanges and quotation systems.

 

5.6 Information
Rights. As long as the Purchaser owns at least five percent (5%) of the Securities originally purchased hereunder, the Company covenants
to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company pursuant to the Exchange Act. As long as the Purchaser owns at least five percent (5%) of the Securities originally purchased
hereunder, if the Company is not required to file reports pursuant to such laws, it will prepare and furnish to the Purchaser and simultaneously
make publicly available in accordance with Rule 144(c) such information as is required for the Purchaser to sell the Securities under
Rule 144. The Company further covenants that it will take such further action as any holder of Securities may reasonably request, all
to the extent required from time to time to enable the Purchaser to sell the Securities without registration under the Securities Act
within the limitation of the exemptions provided by Rule 144.

 

    22 

     

    

 

5.7 Confidentiality.
The Purchaser agrees that it will keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its
investment in the Company) the terms and conditions of this Agreement or any confidential information obtained from the Company pursuant
to the terms of this Agreement (including notice of the Company’s intention to file a registration statement), unless such confidential
information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 5.7 by the Purchaser),
(b) is or has been independently developed or conceived by the Purchaser without use of the Company’s confidential information,
or (c) is or has been made known or disclosed to the Purchaser by a third party without a breach of any obligation of confidentiality
such third party may have to the Company; provided, however, that the Purchaser may disclose confidential information (i) to its attorneys,
accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its
investment in the Company; (ii) to any prospective purchaser of any Securities from the Purchaser, if such prospective purchaser agrees
to be bound by the provisions of this Section 5.7; (iii) to any existing or prospective affiliate, partner, member, stockholder, or wholly
owned subsidiary of the Purchaser in the ordinary course of business, provided that the Purchaser informs such person that such information
is confidential and directs such person to maintain the confidentiality of such information; or (iv) as may otherwise be required by
law, provided that the Purchaser notifies the Company within three (3) Business Days of such disclosure and takes reasonable steps to
minimize the extent of any such required disclosure.

 

5.8 Terms
of Future Financings. Unless otherwise agreed to by the holders of a majority of the then outstanding Preferred Shares, so long as
the Purchaser holds any of the Preferred Shares, upon any issuance of (or announcement of intent to effect an issuance of) any security,
or amendment to (or announcement of intent to effect an amendment to) any security that was originally issued before the issue date,
by the Company, with any term that the Purchaser reasonably believes is more favorable to the holder of such security than, or with a
term in favor of the holder of such security that the Purchaser reasonably believes was not similarly provided, to the Purchaser in the
Subscription Documents, then (i) the Company shall notify the Purchaser of such additional or more favorable term within five (5) Business
Days of the new issuance and/or amendment (as applicable) of the respective security, which notice may include the filing of a current
report on Form 8-K that discloses the issuance of such new security, and (ii) such term, at Purchaser’s option, shall become a
part of the transaction documents with the Purchaser (regardless of whether the Company complied with the notification provision of this
Section 5.8). The types of terms contained in another security that may be more favorable to the purchaser of such security include,
but are not limited to, terms addressing conversion discounts, prepayment rate, conversion lookback periods, interest rates, original
issue discounts, stock sale price, private placement price per share, and warrant coverage. If the Purchaser elects to have the term
become a part of the transaction documents with the Purchaser, then the Company shall immediately deliver to the Purchaser acknowledgment
of such adjustment and/or shall take such further action as the Purchaser may reasonably require (including executing and delivering
amendments to applicable transaction documents) to implement such adjustments in form and substance reasonably satisfactory to the Purchaser
(the “Acknowledgment”) within five (5) Business Days of the Company’s receipt of request from Purchaser (the
“Adjustment Deadline”), provided that the Company’s failure to timely provide the Acknowledgement shall not
affect the automatic amendments contemplated hereby.

 

    23 

     

    

 

5.9 Breach
of Covenants. The Company acknowledges and agrees that if the Company breaches any covenants set forth in this Section 5, in addition
to any other remedies available to the Purchaser pursuant to this Agreement, it will be considered an Event of Default under the Designation.

 

5.10 Transfer
Agent Instructions. The Company shall issue irrevocable instructions to its transfer agent to issue certificates, registered in the
name of the Purchaser or its nominee, upon conversion of the Preferred Shares and exercise of the Warrants, in such amounts as specified
from time to time by the Purchaser to the Company in accordance with the terms thereof (the “Irrevocable Transfer Agent Instructions”).
In the event that the Company proposes to replace its transfer agent, the Company shall provide, prior to the effective
date of such replacement, fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant to this Agreement
(including but not limited to the provision to irrevocably reserve sufficient Common Shares for issuance upon any conversion of the Preferred
Shares and exercise of the Warrants) signed by the successor transfer agent to the Company and the Purchaser. Prior to registration of
the Underlying Securities under the Securities Act or the date on which the Underlying Securities may be sold pursuant to Rule 144 without
any restriction as to the number of Securities as of a particular date that can then be immediately sold, all such certificates shall
bear the restrictive legend specified in Section 4.9 or a similar legend prescribed by the Company’s transfer agent. The Company
warrants that: (a) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5.10 will be given
by the Company to its transfer agent and that the Securities shall otherwise be freely transferable on the books and records of the Company
as and to the extent provided in this Agreement and the Units; (b) it will not direct its transfer agent not to transfer or delay, impair,
and/or hinder its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for Common Shares
to be issued to the Purchaser upon exercise of the Warrants or conversion of or otherwise pursuant to the Preferred Shares as and when
required by the Designation and this Agreement; (c) it will not fail to remove (or direct its transfer agent not to remove or impair,
delay, and/or hinder its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect
thereof) on any certificate for any Common Shares issued to the Purchaser upon exercise of the Warrants or conversion of, or otherwise
pursuant to the Preferred Shares as and when required by the Designation and this Agreement and (d) it will provide any required corporate
resolutions and issuance approvals to its transfer agent within one (1) Business Day of each conversion of the Preferred Shares or exercise
of the Warrants. Nothing in this Section shall affect in any way the Purchaser’s obligations and agreement set forth in Section
5.3 hereof to comply with all applicable prospectus delivery requirements, if any, upon re-sale of the Securities. If the Purchaser provides
the Company, at the cost of the Company, with (i) an opinion of counsel in form, substance and scope customary for opinions in comparable
transactions, to the effect that a public sale or transfer of such Securities may be made without registration under the Securities Act
and such sale or transfer is effected or (ii) the Purchaser provides reasonable assurances that the Securities can be sold pursuant to
Rule 144, the Company shall permit the transfer, and, in the case of the Securities, promptly instruct its transfer agent to issue one
or more certificates, free from restrictive legend, in such name and in such denominations as specified by the Purchaser. The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Purchaser, by vitiating the intent and
purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations
under this Section 5.10 may be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions
of this Section, that the Purchaser shall be entitled, in addition to all other available remedies, to an injunction restraining any
breach and requiring immediate transfer, without the necessity of showing economic loss and without any bond or other security being
required.

 

    24 

     

    

 

5.11 Compliance
with 1934 Act; Public Information Failures. For so long as the Purchaser beneficially owns any of the Securities, the Company shall
comply with the reporting requirements of the 1934 Act and shall continue to be subject to the reporting requirements of the 1934 Act.
During the period that the Purchaser beneficially owns the Securities, if the Company shall (a) fail for any reason to satisfy the requirements
of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information requirements under Rule 144(c)
or (b) if the Company has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company
shall fail to satisfy any condition set forth in Rule 144(i)(2), and, in either such case, the Purchaser is otherwise unable to sell
any of the Securities owned by the Purchaser because such shares are not otherwise freely transferrable (each, a “Public Information
Failure”) then, as partial relief for the damages to the Purchaser by reason of any such delay in or reduction of its ability
to sell the Securities (which remedy shall not be exclusive of any other remedies available pursuant to this Agreement, the Units, or
at law or in equity), the Company shall pay to the Purchaser an amount in cash equal to three percent (3%) of the Purchase Price on each
day of a Public Information Failure and on every thirtieth (30th) day (pro-rated for periods totaling less than thirty (30)
days) thereafter until the date such Public Information Failure is cured, but subject to a cap of ten percent (10%). The payments to
which the Purchaser shall be entitled pursuant to this Section 5.11 are referred to herein as “Public Information Failure Payments.”
Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information
Failure Payments are incurred and (ii) the third Business Day after the event or failure giving rise to the Public Information Failure
Payments is cured.

 

5.12Further
Assurances.Each of the Purchaser and the Company agrees and covenants that at any time and from time to time it will execute
and deliver to the other party such further instruments and documents and take such further action as the other party may reasonably
require within three (3) Business Days of any such request in order to carry out the full intent and purpose of this Agreement and to
comply with state or federal securities laws or other regulatory approvals.

 

    25 

     

    

 

		6.	CONDITIONS
                                            TO THE COMPANY’S OBLIGATION TO SELL

 

The
obligation of the Company hereunder to issue and sell the Units to the Purchaser at the Closing is subject to the satisfaction, at or
before the Closing Date, of each of the following conditions, provided that these conditions are for the Company’s sole benefit
and may be waived by the Company at any time in its sole discretion:

 

(a) The
Purchaser shall have executed this Agreement and delivered the same to the Company.

 

(b) The
Purchaser shall have delivered the Purchase Price in accordance with Section 1 above.

 

(c) The
representations and warranties of the Purchaser shall be true and correct in all material respects as of the date when made and as of
the Closing Date, as though made at that time (except for representations and warranties that speak as of a specific date), and the Purchaser
shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Purchaser at or prior to the Closing Date.

 

(d) No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

		7.	CONDITIONS
                                            TO THE PURCHASER’S OBLIGATION TO PURCHASE

 

The
obligation of the Purchaser hereunder to purchase the Units, on the Closing Date, is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions, provided that these conditions are for the Purchaser’s sole benefit and may be waived
by the Purchaser at any time in its sole discretion:

 

(a) The
Company shall have executed this Agreement and delivered the same to the Purchaser.

 

(b) The
Company shall have delivered to the Purchaser the Units in accordance with Section 1 above.

 

(c) The
Company shall have delivered executed Subscription Documents, or such other instruments as contemplated by this Agreement.

 

(d) The
Irrevocable Transfer Agent Instructions, in form and substance satisfactory to the Purchaser, shall have been delivered to and acknowledged
in writing by the Company’s transfer agent.

 

(e) The
representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as of Closing
Date, as though made at such time (except for representations and warranties that speak as of a specific date) and the Company shall
have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement
to be performed, satisfied or complied with by the Company at or prior to the Closing Date.

 

    26 

     

    

 

(f) No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

(g) No
event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited
to a change in the Exchange Act reporting status of the Company or the failure of the Company to be timely in its Exchange Act reporting
obligations.

 

(h) Company
shall have delivered to the Purchaser (i) a certificate evidencing the formation and good standing of Company and each of its Subsidiaries
in such entity’s jurisdiction of formation issued by the Secretary of State (or comparable office) of such jurisdiction, as of
a date within ten (10) days of the Closing Date; (ii) resolutions adopted by the Company’s Board of Directors at a duly called
meeting or by unanimous written consent authorizing this Agreement and all other documents, instruments and transactions contemplated
hereby.

 

		8.	MISCELLANEOUS

 

8.1 Binding
Agreement. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors
and assigns of the parties. Nothing in this Agreement, expressed or implied, is intended to confer upon any third party any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

8.2 Governing
Law; Consent to Jurisdiction. This Agreement shall be governed by and construed under the laws of the State of New York, without
giving effect to conflicts of laws principles. Each party to this Agreement hereby irrevocably submits to the non-exclusive jurisdiction
of the state and federal courts sitting in Rockland County, New York for the adjudication of any dispute hereunder or in connection with
any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail,
return receipt requested) to such party at the address in effect for notices to it under this agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any manner permitted by law.

 

8.3 Counterparts.
This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic
signature) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and
be valid and effective for all purposes.

 

8.4 Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing
or interpreting this Agreement.

 

    27 

     

    

 

8.5 Notices.
All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to
the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient,
if not, then on the next Business Day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with
written verification of receipt. All communications shall be sent to the Company and to the Purchaser at the addresses set forth on the
signature page to this Agreement or at such other addresses as the Company or Purchaser may designate by ten (10) days’ advance
written notice to the other parties hereto.

 

8.6 Modification;
Waiver. No modification or waiver of any provision of this Agreement or consent to departure therefrom shall be effective only upon
the written consent of the Company and Investors holding a majority of the then outstanding Preferred Shares.

 

8.7 Expenses.
The Company and the Purchaser shall each bear its respective expenses and legal fees incurred with respect to this Agreement and the
transactions contemplated herein.

 

8.8 Delays
or Omissions. It is agreed that no delay or omission to exercise any right, power or remedy accruing to the Purchaser, upon any breach
or default of the Company under the Subscription Documents shall impair any such right, power or remedy, nor shall it be construed to
be a waiver of any such breach or default, or any acquiescence therein, or of or in any similar breach or default thereafter occurring;
nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring.
It is further agreed that any waiver, permit, consent or approval of any kind or character by Purchaser of any breach or default under
this Agreement, or any waiver by any Purchaser of any provisions or conditions of this Agreement must be in writing and shall be effective
only to the extent specifically set forth in writing and that all remedies, either under this Agreement, or by law or otherwise afforded
to the Purchaser, shall be cumulative and not alternative.

 

8.9 Remedies
Cumulative. No remedy herein conferred upon any party is intended to be exclusive of any other remedy and each and every such remedy
shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity or
by statute or otherwise.

 

8.10 Attorneys’
Fees. In the event that any party hereto institutes any legal suit, action, or proceeding, including arbitration, against another
party in respect of a matter arising out of or relating to this Agreement, the prevailing party in the suit, action, or proceeding shall
be entitled to receive, in addition to all other damages to which it may be entitled, the costs incurred by such party in conducting
the suit, action or proceeding, including reasonable attorneys’ fees and expenses, and court costs.

 

8.11 Equitable
Remedies. Each party hereto acknowledges that a breach or threatened breach by such party of any of its obligations under this Agreement
would give rise to irreparable harm to the other parties, for which monetary damages would not be an adequate remedy, and hereby agrees
that in the event of a breach or a threatened breach by such party of any such obligations, each of the other parties hereto shall, in
addition to any and all other rights and remedies that may be available to them in respect of such breach, be entitled to equitable relief,
including a temporary restraining order, an injunction, specific performance and any other relief that may be available from a court
of competent jurisdiction (without any requirement to post bond).

 

8.12 Entire
Agreement. This Agreement and the Exhibits hereto constitute the full and entire understanding and agreement between the parties
with regard to the subjects hereof and no party shall be liable or bound to any other party in any manner by any representations, warranties,
covenants and agreements except as specifically set forth herein.

 

[Signature
Page Follows]

 

    28 

     

    

 

In
Witness Whereof, the parties have executed this
Agreement as of the date first written above.

 

	COMPANY:	 	PURCHASER:
	 	 	 	 	 
	1847 Holdings LLC	 	[NAME OF PURCHASER]
	 	 	 	 	 
	By:	 	 	By:	              
	Name:  	Ellery W. Roberts	 	Name:	 
	Title:	Chief Executive Officer	 	Title:	 

 

	Address: 	590 Madison Avenue	 	Address:	 
	                 	21st Floor	 	 	 
	                 	New York, NY 10022	 	 	 

  

	 	Number of Units:	 
	 	Purchase Price:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]